ICONA H8: The Story Behind Two Millilitres
Behind every great innovation is an idea. Behind ICONA H8 is an independent British company, a founder determined to challenge convention, and a belief that the future of medical aesthetics should be shaped by science, not trends.
Two millilitres.
It’s a remarkably small volume in which to place years of ambition, scientific thinking and product development.
Yet within every syringe of ICONA H8 lies a story that began long before the product reached an aesthetics clinic. A story of British entrepreneurship, pharmaceutical experience, scientific collaboration and the determination to create something different in one of the world’s most competitive industries.
And perhaps most importantly, a story of why the details matter.
The ambition behind the brand
From his roots in North Wales, Arthur Gill has spent much of his professional life working across pharmaceuticals, clinical research and healthcare technology.
Those experiences gave him a particular perspective on an aesthetics industry that was evolving rapidly.
Innovation was everywhere. New products were arriving constantly. But Arthur saw an opportunity for something that occupied a space between the established global giants and the increasingly crowded market of alternative injectable brands. He wanted to build an independent British company that could combine the agility and ambition of a smaller business with the scientific discipline, quality standards and accountability expected in regulated healthcare.
That ambition led to Gill Pharmaceuticals and the creation of ICONA.
“I never wanted ICONA to be just another name in aesthetics. I wanted to create something that had real substance behind it — from the formulation and technology to the standards we set ourselves as a company. We may be an independent British business, but our ambitions have never been small.”
— Arthur Gill, Founder, ICONA
It is a philosophy that has influenced every stage of the company’s development.
For ICONA, the objective was never simply to introduce another injectable product. It was to create a brand with its own identity, its own approach to innovation and, above all, a genuine reason to exist.
Where ambition meets science
The journey from initial concept to finished product required considerably more than an idea.
It involved research, engagement with university researchers, collaboration with scientific and technical specialists, and the development of relationships with international manufacturing partners. These relationships helped shape ICONA’s approach to product development, bringing together different disciplines and perspectives around a common objective.
The process also required navigating the less visible but essential aspects of bringing a medical aesthetics product to market: formulation development, technical assessment, quality-management systems, manufacturing processes and regulatory requirements. It is a journey rarely seen by the practitioner holding the finished product, yet one that fundamentally shapes the business behind it.
Importantly, ICONA has remained independently owned, allowing Gill Pharmaceuticals to retain control of its direction and pursue its long-term ambitions. That independence has become an important part of the company’s identity. It has allowed the business to remain focused on developing its own technologies, maintaining close relationships with technical partners and building a brand around principles rather than passing commercial opportunities.
What began as an ambition in North Wales has gradually developed into a British aesthetics brand with growing international relationships and a clear vision for the future.
A different way of thinking about skin
The development of ICONA H8 began with a simple but important understanding: skin quality involves considerably more than hydration alone.
Skin is a complex biological structure. Its appearance and condition are influenced by hydration, structural proteins, the extracellular matrix and a wide range of interconnected biological processes. Rather than focusing on a single ingredient in isolation, ICONA approached the formulation of H8 with a broader perspective.
This thinking is reflected in the company’s proprietary A.R.T. Technology® — Advanced Regenerative Technology.
At the heart of ICONA H8 is a carefully considered combination of 64 mg of dual-molecular-weight hyaluronic acid, eight amino acids and vitamin C within a 2 ml injectable formulation.
Each component has a distinct role:
- Hyaluronic acid is widely recognised for its ability to attract and retain moisture, helping support skin hydration.
- Amino acids are fundamental building blocks involved in the formation of structural proteins, including collagen;
- while vitamin C plays an essential role in normal collagen formation and contributes antioxidant properties.
The thinking behind A.R.T. Technology® is that skin revitalisation should not be approached through a single ingredient alone, but through a carefully considered formulation that recognises the different components involved in maintaining skin quality.
ICONA H8 brings these ingredients together within a non-crosslinked hyaluronic acid formulation designed for bio-revitalisation, with a focus on hydration and the appearance of skin texture, elasticity and overall quality.
Its philosophy reflects a wider evolution within medical aesthetics.
For many patients, the objective is no longer simply to address individual lines or alter facial characteristics. Increasingly, attention is turning towards maintaining skin quality, supporting a refreshed appearance and achieving results that complement the individual’s natural features. ICONA H8 was developed with this considered approach in mind.
Because sometimes the most successful aesthetic treatment is not the one that announces itself. It is the one that allows the skin to speak for itself.
What you don’t see matters just as much
There is another side to the ICONA story, one that may be less visible than the formulation but is equally important to its founder. In a sector where innovation is often judged by what a product promises, ICONA has placed significant emphasis on how its products are developed, documented, supported and monitored.
Arthur’s experience in regulated healthcare environments has shaped the company’s belief that accountability should remain central throughout a product’s life cycle. The company has also developed a dedicated QR-linked post-market surveillance approach, designed to strengthen product traceability, facilitate practitioner feedback and support ongoing safety monitoring.
This reflects a belief that the relationship between a manufacturer and a healthcare professional should not end when a product leaves the production facility. The experience of the practitioner matters. The ongoing monitoring of a product matters. And above all, the safety and wellbeing of the patient matter.
For ICONA, these are not separate responsibilities. They are part of the same commitment. It is this thinking that distinguishes the company’s wider approach to innovation. Because innovation should not be measured solely by what goes into a syringe. It should also be reflected in everything that surrounds it.
An independent British story with international ambitions
From its beginnings in North Wales, ICONA has continued to develop its presence within the UK and attract interest from international markets. That progress represents an important part of the company’s journey. But Arthur has always believed that successful international growth depends on more than finding new markets. It depends on finding the right people to represent the brand.
People who share the same expectations around professionalism, product knowledge, education and long-term relationships.
Ireland represents an exciting new chapter in that journey.
Through its partnership with Aspire & Co, ICONA H8 is bringing together British product development and innovation with established Irish expertise in professional aesthetics distribution, practitioner education and support.
For ICONA, choosing the right partners has always been as important as developing the right products. In Aspire & Co, the company sees a shared commitment to education, professional standards and building relationships that extend far beyond an initial product introduction. The partnership is built around a common understanding that introducing an innovative injectable treatment requires more than simply making it available to purchase.
Practitioners need appropriate training, clear treatment protocols, confidence in the products they use and access to continuing professional support. By combining their respective expertise, ICONA and Aspire & Co aim to establish H8 within Ireland through a considered, practitioner-focused approach. It is a relationship that reflects the wider philosophy of the business: sustainable growth is built on trust, shared standards and a genuine commitment to the people who use its products.
A celebration of what matters
On 24 October 2026, ICONA H8 and Aspire & Co will proudly support The Diamond Awards Ireland 2026 as Gold Sponsors.
It is an association that feels particularly appropriate. Because while the evening will rightly celebrate outstanding achievements, talent and innovation, its deeper significance lies in recognising the people and businesses who believe that excellence and patient safety must go hand in hand. Those principles are woven into the ICONA story.
They influenced the earliest decisions behind the brand, continue to shape its approach to product development and remain central to its ambitions for the future. For Arthur, the journey from an idea in North Wales to a growing international business has never been simply about creating another name in aesthetic medicine.
It has been about building something with substance. Something founded on scientific thinking, developed with care and supported by the standards and responsibilities that medical professionals rightly expect. The company continues to evolve, new opportunities are emerging and its international ambitions remain strong. But the original vision has not changed.
To create products with purpose. To innovate responsibly. And to build a British brand that earns its place in an increasingly sophisticated global aesthetics industry.
Which brings us back to those two millilitres.
Because the real story of ICONA H8 isn’t simply what goes into the syringe.
It’s everything that went into creating it.
ICONA H8
Designed for Skin. Not for Trends.
